Gsa Capital Partners LLP Veracyte, Inc. Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $2.02 Million - $2.74 Million	98,214 New	98,214 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $816,200 - $1.37 Million	49,228 New	49,228 $817,000
Q2 2022 Aug 09, 2022	SELL	$15.45 - $29.52 $168,605 - $322,151	-10,913 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$21.94 - $42.51 $239,431 - $463,911	10,913 New	10,913 $301,000
Q2 2020 Aug 11, 2020	SELL	$19.49 - $28.11 $243,449 - $351,122	-12,491 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $201,479 - $376,853	12,491 New	12,491 $304,000
Q4 2019 Feb 12, 2020	SELL	$20.78 - $29.99 $241,546 - $348,603	-11,624 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $1.1 Million - $1.43 Million	-46,271 Reduced 79.92%	11,624 $279,000
Q2 2019 Aug 06, 2019	BUY	$22.1 - $28.56 $383,302 - $495,344	17,344 Added 42.77%	57,895 $1.65 Million
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $372,588 - $799,822	-31,049 Reduced 43.36%	40,551 $1.02 Million
Q4 2018 Feb 12, 2019	BUY	$9.15 - $14.85 $362,340 - $588,060	39,600 Added 123.75%	71,600 $901,000
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $130,835 - $173,168	13,700 Added 74.86%	32,000 $306,000
Q2 2018 Aug 09, 2018	BUY	$5.39 - $9.66 $98,637 - $176,778	18,300 New	18,300 $171,000
Q4 2017 Feb 14, 2018	SELL	$6.05 - $9.37 $156,090 - $241,745	-25,800 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$7.81 - $8.77 $201,498 - $226,266	25,800	25,800 $226,000

316

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.23B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.